Alan Dove
Impact in
-
- Glycosylation and Glycoproteins Research
- Advanced biosensing and bioanalysis techniques
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
Papers in
-
- Genetics, Bioinformatics, and Biomedical Research 5
-
- Biotechnology and Related Fields 13
- Health and Medical Research Impacts 5
- Co-authors
- Kelly A. Martin (1 shared paper)John Hodgson (1 shared paper)Xiuying Qi (1 shared paper)Jìng Guo (1 shared paper)David A. Bennett (1 shared paper)Weizhong Yang (1 shared paper)Weili Xu (1 shared paper)Laura Bonetta (1 shared paper)
- Journals
- Nature Medicine (41 papers)Nature Biotechnology (36 papers)Science (16 papers)Nature Methods (6 papers)Journal of Clinical Investigation (6 papers)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Alan Dove
93 papers receiving 893 citations
Peers
Comparison fields: 5 of 138
- Molecular Biology 530
- Biotechnology 45
- Spectroscopy 76
- Immunology and Allergy 25
- Biophysics 24
Countries citing papers authored by Alan Dove
This map shows the geographic impact of Alan Dove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Dove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Dove more than expected).
Fields of papers citing papers by Alan Dove
This network shows the impact of papers produced by Alan Dove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Dove. The network helps show where Alan Dove may publish in the future.
Co-authors
The 19 scholars most cited alongside Alan Dove, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 137 | |
| 2 | 1999 | 103 | |
| 3 | 1999 | 72 | |
| 4 | 2002 | 72 | |
| 5 | 2002 | 66 | |
| 6 | 2002 | 52 | |
| 7 | 2003 | 50 | |
| 8 | 2000 | 43 | |
| 9 | 2002 | 35 | |
| 10 | 1999 | 25 | |
| 11 | Metastatic carcinoma of the hand. | 1983 | 20 |
| 12 | 2007 | 13 | |
| 13 | 2001 | 13 | |
| 14 | 2018 | 11 | |
| 15 | 2006 | 11 | |
| 16 | 2024 | 10 | |
| 17 | 2001 | 10 | |
| 18 | 1985 | 9 | |
| 19 | 1998 | 9 | |
| 20 | 1985 | 8 |
About Alan Dove
Alan Dove is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Reproductive Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 113 papers that have together received 972 indexed citations. Recurring topics across this work include Biotechnology and Related Fields (13 papers), Science, Research, and Medicine (12 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Biomedical Ethics and Regulation (6 papers), Health and Medical Research Impacts (5 papers), Pharmaceutical Economics and Policy (5 papers), Genetics, Bioinformatics, and Biomedical Research (5 papers) and Science Education and Perceptions (3 papers). The work is most often cited by research in Molecular Biology (530 citations), Biotechnology (45 citations), Spectroscopy (76 citations), Immunology and Allergy (25 citations) and Biophysics (24 citations). Alan Dove has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Kelly A. Martin, John Hodgson, Xiuying Qi, Jìng Guo, David A. Bennett, Weizhong Yang, Weili Xu, Laura Bonetta, Andrew Marshall and Jing Wang. Their work appears in journals such as Nature Medicine, Nature Biotechnology, Science, Nature Methods and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.